For: | Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C. Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World J Gastrointest Oncol 2014; 6(5): 104-111 [PMID: 24834140 DOI: 10.4251/wjgo.v6.i5.104] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v6/i5/104.htm |
Number | Citing Articles |
1 |
Eric Freund, Kim Rouven Liedtke, Julia van der Linde, Hans-Robert Metelmann, Claus-Dieter Heidecke, Lars-Ivo Partecke, Sander Bekeschus. Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37169-3
|
2 |
Jorja Braden, Prunella Blinman, Ashanya Malalasekera, Kim Kerin-Ayres, Jarrah Spencer, Natalie Southi, Janette L. Vardy. The utility of surveillance CT scans in a cohort of survivors of colorectal cancer. Journal of Cancer Survivorship 2023; 17(4): 1202 doi: 10.1007/s11764-021-01155-y
|
3 |
Sara Khor, Eric C. Haupt, Erin E. Hahn, Lindsay Joe L. Lyons, Veena Shankaran, Aasthaa Bansal. Racial and Ethnic Bias in Risk Prediction Models for Colorectal Cancer Recurrence When Race and Ethnicity Are Omitted as Predictors. JAMA Network Open 2023; 6(6): e2318495 doi: 10.1001/jamanetworkopen.2023.18495
|
4 |
Eric Freund, Kim-Rouven Liedtke, Lea Miebach, Kristian Wende, Amanda Heidecke, Nagendra Kumar Kaushik, Eun Ha Choi, Lars-Ivo Partecke, Sander Bekeschus. Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells In vitro. Cancers 2020; 12(1): 122 doi: 10.3390/cancers12010122
|
5 |
Shibnath Ghatak, Vincent C. Hascall, Nikos Karamanos, Roger R. Markwald, Suniti Misra. Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through β-catenin/MDR1 signaling to sustain chemoresistance. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.906260
|
6 |
Shibnath Ghatak, Vincent C. Hascall, Roger R. Markwald, Suniti Misra. Hyaluronan. Biology of Extracellular Matrix 2023; 14: 119 doi: 10.1007/978-3-031-30300-5_7
|
7 |
Allison Y. Ye, Winson Y. Cheung, Karen J. Goddard, Daniel Horvat, Robert A. Olson. Follow-up patterns of cancer survivors: a survey of Canadian radiation oncologists. Journal of Cancer Survivorship 2015; 9(3): 388 doi: 10.1007/s11764-014-0390-2
|
8 |
Mark Jeffery, Brigid E Hickey, Phillip N Hider. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database of Systematic Reviews 2019; 2019(9) doi: 10.1002/14651858.CD002200.pub4
|
9 |
Linda Aagaard Rasmussen, Henry Jensen, Line Flytkjær Virgilsen, Alina Zalounina Falborg, Henrik Møller, Peter Vedsted. Healthcare utilisation in general practice and hospitals in the year preceding a diagnosis of cancer recurrence or second primary cancer: a population-based register study. BMC Health Services Research 2019; 19(1) doi: 10.1186/s12913-019-4757-y
|
10 |
Benjamin Allaire, Robbie Skinner, Grant King, Amanda Honeycutt, Dominick Esposito. An economic evaluation of reducing colorectal cancer surveillance intensity. Journal of Comparative Effectiveness Research 2022; 11(2): 99 doi: 10.2217/cer-2021-0065
|
11 |
Sharlene Gill, Jeffrey A. Meyerhardt, Monica Arun, Christine M. Veenstra. Translating IDEA to Practice and Beyond: Managing Stage II and III Colon Cancer. American Society of Clinical Oncology Educational Book 2019; (39): 226 doi: 10.1200/EDBK_237443
|
12 |
Eric Freund, Kim Rouven Liedtke, Rebecca Gebbe, Amanda Kathleen Heidecke, Lars-Ivo Partecke, Sander Bekeschus.
In Vitro Anticancer Efficacy of Six Different Clinically Approved Types of Liquids Exposed to Physical Plasma. IEEE Transactions on Radiation and Plasma Medical Sciences 2019; 3(5): 588 doi: 10.1109/TRPMS.2019.2902015
|
13 |
Knut Magne Augestad, Marianne A Merok, Dejan Ignatovic. Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clinical Medicine Insights: Oncology 2017; 11 doi: 10.1177/1179554917690766
|
14 |
Mark Jeffery, Brigid E Hickey, Phil N Hider, Adrienne M See. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database of Systematic Reviews 2016; doi: 10.1002/14651858.CD002200.pub3
|
15 |
Min Young Park, In Ja Park, Hyo Seon Ryu, Jay Jung, Minsung Kim, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim. Optimal postoperative surveillance strategies for stage III colorectal cancer. World Journal of Gastrointestinal Surgery 2021; 13(9): 1012-1024 doi: 10.4240/wjgs.v13.i9.1012
|
16 |
Michele M. Gage, Matthew T. Hueman. Colorectal Cancer Surveillance: What Is the Optimal Frequency of Follow-up and Which Tools Best Predict Recurrence?. Current Colorectal Cancer Reports 2017; 13(4): 316 doi: 10.1007/s11888-017-0382-5
|